Skip to main content
. 2022 Apr 4;12:860563. doi: 10.3389/fonc.2022.860563

Table 2.

TP53 co-mutation is not associated with prognosis in EGFR-mutated NSCLC patients.

Study TP53-mut vs. TP53-wt EGFR-TKI Predictor
mOS (months) mPFS (months) ORR
Rachiglio 2019 (23) 18.9 vs. 23
(P = 0.19)
12.3 vs. 9.9
(P = 0.29)
N/A N/A
Labbé 2017 (39) 70.2 vs.71.2
(P = 0.39)
10.0 vs. 16.8
(P = 0.06)
54% vs. 66%
(P = 0.42)
YES

N/A, No Available.